BrismarJDavisKRDallowRLBrismarG. Unilateral endocrine exophthalmos. Diagnostic problems in association with CT. Neuroradiology1976; 12: 21–4.
2.
MoseleyIFSandersMD. Computerized axial tomography in neuro-ophthalmology. London: Chapman and Hall, 1982.
3.
NowinskiTSFlanaganJC. Evaluation of exophthalmos and thyroid ophthalmopathy. In: GonzalezCFBeckerMHFlanaganJC eds. Diagnostic imaging in ophthalmology. New York: Springer, 1986:189–200.
4.
LloydGAS. The orbit and eye. In: SuttonD, ed. A textbook of radiology and imaging. Edinburgh: Churchill Livingstone, 1987:1316–41.
5.
CharDHUnsoldRSobelDFSalvoliniUNewtonTH. Computed tomography: ocular and orbital pathology. In: NewtonTHBilaniukLT, eds. Radiology of the eye and orbit. New York: Raven Press, 1990:9.1–9.64.
6.
JohnsonMIAshtonCHThompsonJW. An in depth study of long term users of transcutaneous electrical nerve stimulation (TENS). Implications for clinical use of TENS. Pain1991; 44: 221–9.
7.
ErikssonMBESjolundBHNielzenS. Long term results of peripheral conditioning stimulation as an analgesic measure in chronic pain. Pain1979; 6: 335–47.
EustaceDTrehanARajuKSDeriasNAbdominal pain and vaginal bleeding associated with schistosomiasis of the genital tract. J Obstet Gynaecol1992; 12: 427–8.
10.
BlandKGGelfandM. The effects of Schistosomiasis on the cervix uteri in the African female. J Obstet Gynecol Br Commnw1970; 77: 1127–31.
11.
YoussefAFFayedMMShafeekMA. Bilharziasis of the cervix uteri. J Obstet Gynecol Br Commnw1970; 77: 847–51.
12.
OlufemiWilliams A. Pathology of schistosomiasis of the uterine cervix due to S. haematobium. Am J Obstet Gynecol1967; 98: 784–91.
13.
PahorAL. Ear, nose and throat in Ancient Egypt, Part I. J Laryng Otol1992; 106: 677–87.
14.
FoyMFaggP. Medicolegal reporting in orthopaedic trauma. London.
15.
BrinMF. Interventional neurology: treatment of neurological conditions with local injections of botulinum toxin. Arch Neurobiol1991; 54(Suppl 3):7–23.
AAO Statement. Botulinum toxin therapy of eye muscle disorders. Safety and effectiveness. American Academy of Ophthalmology. Ophthalmology1989; Part 2(Sept): 37–41.
18.
American Academy of Neurology. The clinical usefulness of botulinum toxin-A in treating neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology1990; 40: 1332–6.
19.
American Academy of Otolaryngology-Head and Neck Surgery Policy Statement: Botox for spasmodic dysphonia. AAP-HNS Bull1990; 9: 8.
20.
NIH Censensus Development Conference Consensus Statement. Clinical use of botulinum toxin. NIH Cons Dev Conf1990; 8: 12–14.
21.
BrinMFFahnSMoskowitzCBBlitzerAFriedmanAShaleHMInjections of botulinum toxin for the treatment of focal dystonia, [abstract]Neurology1986; 36(Suppl 1):120.
22.
BlitzerABrinMFFahnSLangeDLovelaceRE. Botulinum toxin (BOTOX) for the treatment of ‘spastic dysphonia’ as part of a trial of toxin injections for the treatment of other cranial dystonias [letter]. Laryngoscope1986; 96: 1300–1.
SandersDBMasseyEWBuckleyEC. EMG monitoring of botulinum toxin in blepharospasm, [abstract]Neurology1985; 35(Suppl 1):272.
25.
LorentzITSubramaniamSSYiannikasC. Treatment of idiopathic spasmodic torticollis with botulinum toxin A: a double-blind study on twenty-three patients. Mov Disord1991; 6: 145–50.
26.
DasGuptaBR, ed. Botulinum and Tetanus neurotoxins: neurotransmission and biomedical aspects. New York: Plenum, 1992.
27.
QuinnNHallettM. Dose standardisation of botulinum toxin [letter]. Lancet1989; i: 964.
28.
QuinnNPHallettM. Dose standardisation of botulinum toxin — published erratum correction. Lancet1989; i: 1989.
29.
SellinLC. The action of botulinum toxin at the neuromuscular junction. Med Biol1981; 59: 11–20.
30.
BrinMFBlitzerAStewartCPineZMBorg-SteinJMillerJDisorders with excessive muscle contraction: Candidates for treatment with intramuscular botulinum toxin (‘botox”). In: DasGuptaBR, ed. Botulinum and tetanus neurotoxins: neurotransmission and biomedical aspects. New York: Plenum, 1993.
31.
GreenePKangUFahnSBrinMMoskowitzCFlasterE. Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis. Neurology1990; 40: 1213–18.
32.
HoweGM. Aspects of medical geography in Great Britain. In: HarrisonGAGibsonJB, eds. Man in urban environments. Oxford: Oxford University Press, 1976:176–204.
33.
RussellWMS. Man about town: man in urban environments. Biol Hum Affairs1978; 43: 45–59.
34.
FordEB. Ecological genetics, 4th edn.London: Chapman and Hall, 1975.
35.
RoseGA. Epidemiological evidence for the effects of urban environment. In: HarrisonGAGibsonJB, eds. Man in urban environments. Oxford: Oxford University Press, 1976:205–16.
36.
BarrDGDKirkJMLaingSC. Outcome in tyrosinaemia type H. Arch Dis Child1991; 66: 1249–50.
37.
RehakASelimMMYadavG. Richner-Hanhart syndrome (tyrosinaemia II) report of four cases without ocular involvement. Br J Dermatol1981; 104: 469–75.